Product Details for NDA 017020
PANWARFIN (WARFARIN SODIUM)
2MG
Marketing Status: Discontinued
2.5MG
Marketing Status: Discontinued
5MG
Marketing Status: Discontinued
7.5MG
Marketing Status: Discontinued
10MG
Marketing Status: Discontinued
2MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: PANWARFIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017020
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
PANWARFIN (WARFARIN SODIUM)
Proprietary Name: PANWARFIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017020
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
2.5MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: PANWARFIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017020
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
PANWARFIN (WARFARIN SODIUM)
Proprietary Name: PANWARFIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017020
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
5MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: PANWARFIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017020
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
PANWARFIN (WARFARIN SODIUM)
Proprietary Name: PANWARFIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017020
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
7.5MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: PANWARFIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017020
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
PANWARFIN (WARFARIN SODIUM)
Proprietary Name: PANWARFIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017020
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
10MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: PANWARFIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017020
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: PANWARFIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017020
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information